1. Home
  2. ACHV vs NNOX Comparison

ACHV vs NNOX Comparison

Compare ACHV & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.59

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Logo NANO-X IMAGING LTD

NNOX

NANO-X IMAGING LTD

HOLD

Current Price

$1.95

Market Cap

137.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHV
NNOX
Founded
N/A
2011
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medical Electronics
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
172.0M
137.8M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
ACHV
NNOX
Price
$4.59
$1.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$14.67
$5.00
AVG Volume (30 Days)
1.2M
1.3M
Earning Date
05-11-2026
04-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$147.55
Revenue Next Year
N/A
$81.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$1.59
52 Week High
$6.15
$5.72

Technical Indicators

Market Signals
Indicator
ACHV
NNOX
Relative Strength Index (RSI) 48.02 52.41
Support Level $4.09 $1.63
Resistance Level $4.98 $3.09
Average True Range (ATR) 0.40 0.10
MACD -0.12 0.05
Stochastic Oscillator 7.56 90.00

Price Performance

Historical Comparison
ACHV
NNOX

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

About NNOX NANO-X IMAGING LTD

Nano X Imaging Ltd is focused on driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The group combines affordable imaging hardware, progressive AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The three segments are composed of the Nanox.ARC segment, the AI and software solutions segment, and the Radiology services segment. Key revenue is generated from Radiology Services.

Share on Social Networks: